Related Experiment Video

Updated: Jul 5, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

600

[Cardiology: what's new in 2023]

Adil Salihu1, David Meier1, Nadia Kilani1

  • 1Service de cardiologie, Centre hospitalier universitaire vaudois et Faculté de biologie et médecine, Université de Lausanne, 1011 Lausanne.

Revue Medicale Suisse
|January 17, 2024
PubMed

Insights

2023 brought significant cardiology updates, including new European Society of Cardiology (ESC) guidelines for acute coronary syndrome (ACS), endocarditis, heart failure, and cardiovascular prevention. This review highlights key advancements in cardiac care.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Clinical Cardiology

Background:

  • 2023 saw a surge in cardiology research across diverse subspecialties.
  • The European Society of Cardiology (ESC) released updated guidelines impacting clinical practice.

Approach:

  • This review synthesizes major advancements in cardiology published in 2023.
  • Focuses on significant updates from the European Society of Cardiology (ESC).

Key Points:

  • Revised guidelines for acute coronary syndrome (ACS) management.
  • Updated recommendations for endocarditis treatment.
  • New guidance on heart failure and cardiovascular prevention strategies.

Conclusions:

  • The Cardiology Department of CHUV summarizes pivotal 2023 cardiology developments.
  • These updates are crucial for contemporary cardiovascular disease management.

More Related Videos

Author Spotlight: Advancements in Intracardiac Echocardiography for Atrial Anatomy Assessment04:29

Author Spotlight: Advancements in Intracardiac Echocardiography for Atrial Anatomy Assessment

Published on: June 30, 2023

926
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

1.6K

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
665
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
449
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K